By Andrea Hargraves 
“a A woman will live about 40% of her life in menopause. “How can you not treat a woman knowing that she will have a higher risk of cardiovascular disease, Alzheimer's disease, more depression” and a greater likelihood of an osteoporotic fracture of the femoral neck, asked the clinical pathologist, who specializes in anti-aging medicine and hormonal modulation.
In an interview with Lusa on the occasion of World Women's Health Day, which falls this week, the specialist expressed her regret that many doctors link hormone therapy to breast cancer, and confuse biologically identical hormones with biologically mismatched hormones.
“A bioidentical hormone is a hormone that is chemically similar to ours. (…) We cannot confuse one with the other,” he warned.
As he explained, the study linking hormone therapy to breast cancer, from 2002, was based on hormones that were being used at the time in the United States, which had “no relation” to current bioidentical hormones.
Furthermore, the study was “highly biased,” because it included women between the ages of 50 and 79, many of whom already had degeneration.
Evony Mirpuri said the risk of breast cancer in women who take bioidentical hormone therapy is slightly lower than in those who do not because the treatment reduces “stress,” which can lead to cancer.
In response to criticism that there is a lack of studies on this treatment, the specialist responds that bioidentical hormones have been used for more than 60 years, and some such as dissected porcine thyroid, the first bioidentical hormone to be used, have been used for more than 100 years. .
“Hormone therapy is preventive and does not cause cancer,” the doctor said. It protects against osteoporosis, cardiovascular risks, reduces the risk of Alzheimer's disease by 40%, reduces the risk of colon tumors, in addition to stimulating the entire innate immune system.
Recalling that 25% of femoral neck fractures due to osteoporosis result in death within the first year, the doctor asked: “Tell me if you know of any treatment so cheap that at the same time prevents so many diseases that cause so many deaths among women.”
According to Ivone Mirpuri, only 30% of menopausal women experience hot flashes, but all will experience other symptoms, such as vaginal dryness, atrophy of the mucous membranes, urinary incontinence, decreased libido, and increased sagging skin on the face and body. Feeling of an empty headache, with lack of concentration and poor memory.
In 70%, blood pressure rises and cholesterol begins to rise in an attempt to supply the hormones that are no longer produced during menopause.
Without hormones, a woman would experience more dementia, more depression, more allergies, more poor sleep quality, and body aches.
The result is that these women are overmedicated with anxiolytics, antidepressants, anti-inflammatories, antihypertensives, antihistamines and analgesics.
“What I see in my clinical practice for 16 years in this treatment is that women are treated poorly because doctors understand that hormones cause cancer, which is wrong.”
The doctor acknowledged that many doctors use bioidentical hormones, which carry risks when associated with unhealthy lifestyles, but reiterated that bioidentical hormones protect health.
He stressed that hormonal treatment must be linked to other important pillars, including nutritional supplements and avoiding unhealthy lifestyles such as consuming coffee, tobacco, alcohol, anxiolytics and antidepressants, some of which increase the risk of breast cancer.
He criticized, “The same doctor who is afraid to give hormones to women will give antidepressants.”
He concluded: “The national scenario must change, and women have the right to receive treatment during menopause, so that we do not have what we increasingly have in our country: an over-added anxiolytics and anti-depressants, unproductive, dependent and disturbed society.” “Unhappy.”
Read also: Six things you should do before entering menopause
Download our free app.
Consumer's Choice for the eighth consecutive year in online journalism and the 2024 Producer of the Year.
*Study by e Netsonda, November. And ten. Product of the Year 2023 – pt.com